FDA Inspection 1001450 — AmerisourceBergen Drug Corp.

AmerisourceBergen Drug Corp. — FEI 3007181228

The FDA completed an inspection of AmerisourceBergen Drug Corp. on Jan 17, 2017 in Morrisville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jan 17, 2017
Fiscal Year
2017
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Morrisville, NC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.